Drugs / SNS-314
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00519662 | Aug 2007 → Mar 2009 | cancer | Sunesis Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SNS-314 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00519662 ↗ |
| Known as | SNS-314 MESYLATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL482767 ↗ |
| Action | Inhibit | “SNS-314, a Novel Aurora Kinase Inhibitor” NCT00519662 ↗ |
| Modality | Small molecule | — CHEMBL482767 ↗ |